Condensed Consolidated Statements of Cash Flow (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities:
Net Income/(Loss)	$ 9,536,660	$ (3,103,789)
Adjustments to reconcile Net Loss to Net Cash provided by/(used in) operations:
Depreciation and amortization	3,516,851	1,169,001
Debt discount amortization		109,667
Employee stock awards	699,500	255,300
Stock grants	66,914	76,766
Contingent consideration payable fair value	(56,638)	(27,968)
Allowance for doubtful accounts	71,157	15,906
Gain on disposal of assets	(12,044)
Reduction in right of use asset	27,087	90,321
Loss on Jagemann Munition Components		1,000,000
Changes in Current Assets and Liabilities
Accounts receivable	2,124,556	(1,145,584)
Due to (from) related parties		150
Inventories	(12,072,607)	(2,110,684)
Prepaid expenses	1,114,473	214,014
Deposits	(3,119,492)	(156,184)
Accounts payable	7,021,584	1,095,093
Accrued liabilities	(208,131)	847,466
Operating lease liability	(39,203)	(89,455)
Net cash provided by/(used in) operating activities	8,670,667	(1,759,980)
Cash flows from investing activities
GDI acquisition	(50,651,444)
Purchase of equipment	(1,611,316)	(471,882)
Proceeds from disposal of assets	59,800
Net cash used in investing activities	(52,202,960)	(471,882)
Cash flow from financing activities
Payments on inventor facility	(832,143)
Proceeds from factoring liability	23,651,000	6,952,000
Payments on factoring liability	(24,397,199)	(7,050,191)
Payments on assumed debt from GDI	(50,000,000)
Proceeds from inventory facility		1,758,003
Proceeds from paycheck protection program notes		1,051,985
Payments on note payable - related party	(150,775)	(247,490)
Payments on insurance premium note payment	(415,003)	(129,510)
Payments on note payable	(4,000,000)
Common stock issued for exercised warrants	477,811	30,304
Common stock issuance costs	(3,170,422)
Sale of preferred stock	35,000,000
Net cash provided by/(used in) financing activities	(23,836,731)	2,365,101
Net increase/(decrease) in cash	(67,369,024)	133,239
Cash, beginning of period	118,341,471	884,274
Cash, end of period	50,972,447	1,017,513
Supplemental cash flow disclosures
Interest	189,116	160,195
Income taxes
Non-cash investing and financing activities:
Acquisition stock issuances	132,645,000
Insurance premium note payment	1,693,764
Dividends accumulated on preferred stock	337,745
Operating lease liability		737,680
Note payable related party		2,635,797
Stock subscription receivable		$ 1,840,910